3SBio Inc

Common Name
3SBio
Country
China (Mainland)
Sector
Healthcare
Industry
Biotechnology
Employees
6,268
Ticker
1530
Exchange
HONG KONG EXCHANGES AND CLEARING LTD
Description
3SBio Inc. is a prominent biotechnology company primarily engaged in the research, development, manufacturing, and commercialization of biopharmaceutical products. Its core focus lies in developing in...

3SBio's GHG Emissions Data Preview

In 2024, 3SBio completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).

However, 3SBio has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.

Metric (tCO2e)2024202320222021 - 2017
Total Scope 1
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
0000000
Total Scope 2
Market-Based
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Location-Based
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
0000000
Unspecified Calculation Method
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 3
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 1 Revenue Intensity (tCO2e/$M)
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
0000000
Download Data

Verified Sources Behind 3SBio’s Greenhouse Gas (GHG) Emissions Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore 3SBio’s data sources below and access millions more through our Disclosure Search.

a. 3SBio's ESG Report 2024
a. 3SBio's ESG Report 2024
b. 3SBio's ESG Report 2022
b. 3SBio's ESG Report 2022

Insights into 3SBio's Operational Emissions

In 2024, the total operational greenhouse gas (GHG) emissions of 3SBio amounted to 67,270.87 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a

Compared to 2023, the total operational greenhouse gas (GHG) emissions of 3SBio increased by 10.92%, suggesting that the company faced challenges in reducing its emissions from its core operations. a

3SBio's Scope 1 Emissions Over Time

2020202120222023202403.5 k7 k10.5 k14 ktCO2e+1%+10%+61%+14%
  • Total Scope 1
  • Year-over-Year Change

What are 3SBio's Scope 1 emissions?

In 2024, the total Scope 1 emissions of 3SBio were 13,304.07 metric tons of CO₂ equivalent (tCO₂e). a

Has 3SBio reduced its Scope 1 emissions over time?

Since 2020, 3SBio's Scope 1 emissions have increased by 104.17%, reflecting a rising long-term trend in Scope 1 emissions over time. a b

Compared to the previous year (2023), 3SBio's Scope 1 emissions increased by 14.07%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations. a

What are 3SBio's Scope 2 emissions?

In 2024, 3SBio reported Scope 2 greenhouse gas (GHG) emissions of 55,832.05 tCO₂e using the market-based method and 53,966.8 tCO₂e using the location-based method. a

Has 3SBio reduced its Scope 2 emissions over time?

Compared to the previous year (2023), 3SBio's Scope 2 emissions (Location-Based) rose by 10.17% in 2024, suggesting that the company faced challenges in reducing emissions from purchased electricity and energy a

What methodology does 3SBio use for Scope 2 reporting?

In 2024, 3SBio reported its Scope 2 emissions using the market-based method and using the location-based method. a

3SBio's Scope 2 Emissions Over Time

20202021202220232024015 k30 k45 k60 ktCO2e
  • Total Scope 2 Location-Based
  • Total Scope 2 Market-Based
  • Total Scope 2 (Unspecified Calculation Method)

Insights into 3SBio’s GHG Emissions Intensity Compared to Industry Peers

In 2024, 3SBio reported Scope 1 greenhouse gas (GHG) emissions of 13,304.07 tCO₂e and total revenues of USD 1,364 millions. This translates into an emissions intensity of 9.75 tCO₂e per millions USD. a

3SBio's Scope 1 Emissions Intensity Compared to Peers

0.5102005,000100,000Scope 1 Emissions (tCO2e)2202002,00020,000Revenues (Millions of USD)AASInnoCare PharmaYear: 2023Scope 1: 20 tCO2eRevenue: $M 104Scope 1 Intensity: 0.19 tCO2e/$MAntengeneYear: 2023Scope 1: 45 tCO2eRevenue: $M 10Scope 1 Intensity: 4.37 tCO2e/$MShanghai Henlius BiotechYear: 2023Scope 1: 6,909 tCO2eRevenue: $M 830Scope 1 Intensity: 8.32 tCO2e/$MRemeGenYear: 2024Scope 1: 54 tCO2eRevenue: $M 234Scope 1 Intensity: 0.23 tCO2e/$MGenscript BiotechYear: 2024Scope 1: 39,377 tCO2eRevenue: $M 4,637Scope 1 Intensity: 8.49 tCO2e/$MAAAscentage PharmaYear: 2023Scope 1: 2,081 tCO2eRevenue: $M 34Scope 1 Intensity: 61.05 tCO2e/$MShanghai Junshi BiosciencesYear: 2024Scope 1: 5,308 tCO2eRevenue: $M 267Scope 1 Intensity: 19.88 tCO2e/$MEverest MedicinesYear: 2023Scope 1: 0 tCO2eRevenue: $M 19Scope 1 Intensity: 0.02 tCO2e/$MInnovent BiologicsYear: 2023Scope 1: 65 tCO2eRevenue: $M 953Scope 1 Intensity: 0.07 tCO2e/$MAkesoYear: 2024Scope 1: 6,408 tCO2eRevenue: $M 318Scope 1 Intensity: 20.17 tCO2e/$MAAAurisco PharmaceuticalYear: 2024Scope 1: 2,731 tCO2eRevenue: $M 202Scope 1 Intensity: 13.51 tCO2e/$MCARsgen Therapeutics HoldingsYear: 2021Scope 1: 117 tCO2eRevenue: $M 4Scope 1 Intensity: 28.91 tCO2e/$MZai LabYear: 2023Scope 1: 15 tCO2eRevenue: $M 267Scope 1 Intensity: 0.06 tCO2e/$MSSSichuan Kelun-Biotech BiopharmaceuticalYear: 2023Scope 1: 6,335 tCO2eRevenue: $M 237Scope 1 Intensity: 26.78 tCO2e/$MZhifeiYear: 2023Scope 1: 14,211 tCO2eRevenue: $M 7,446Scope 1 Intensity: 1.91 tCO2e/$MKintor PharmaceuticalYear: 2021Scope 1: 29 tCO2eRevenue: $M 5Scope 1 Intensity: 5.35 tCO2e/$MAscletis PharmaYear: 2023Scope 1: 422 tCO2eRevenue: $M 9Scope 1 Intensity: 48.50 tCO2e/$MVIVA Biotech HoldingsYear: 2022Scope 1: 1,404 tCO2eRevenue: $M 373Scope 1 Intensity: 3.76 tCO2e/$MPharmaron BeijingYear: 2024Scope 1: 34,268 tCO2eRevenue: $M 1,682Scope 1 Intensity: 20.37 tCO2e/$MJacobio Pharmaceuticals GroupYear: 2023Scope 1: 34 tCO2eRevenue: $M 10Scope 1 Intensity: 3.48 tCO2e/$MAsymchem Laboratories (Tianjin)Year: 2023Scope 1: 46,854 tCO2eRevenue: $M 1,101Scope 1 Intensity: 42.55 tCO2e/$MWuXi Biologics (Cayman)Year: 2023Scope 1: 32,687 tCO2eRevenue: $M 2,603Scope 1 Intensity: 12.56 tCO2e/$MAlphamab OncologyYear: 2023Scope 1: 3,970 tCO2eRevenue: $M 34Scope 1 Intensity: 117.90 tCO2e/$M3SBioYear: 2024Scope 1: 13,304 tCO2eRevenue: $M 1,364Scope 1 Intensity: 9.75 tCO2e/$M

How does 3SBio's GHG emissions intensity compare to its peers?

In 2024, 3SBio reported a Scope 1 emissions intensity of 9.75 tCO₂e per millions USD. Compared to the peer group median of 8.49 , this places the company above its industry benchmark, indicating it is less carbon-efficient than most competitors. a

Where does 3SBio rank on GHG emissions intensity within its industry?

In 2024, 3SBio ranked 13 out of 23 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD). a

3SBio is therefore positioned in the mid-range of its industry, neither a clear leader nor a laggard in carbon efficiency. a

Want Full Access to 3SBio's GHG Emissions Dataset?
Sign Up